Literature DB >> 7802102

Fluoxetine and extrapyramidal side effects.

D M Coulter1, P I Pillans.   

Abstract

OBJECTIVE: The authors' goal was to determine whether fluoxetine is associated with extrapyramidal side effects.
METHOD: They assessed the notifications of extrapyramidal manifestations in patients given fluoxetine in the New Zealand Intensive Medicines Monitoring Programme, a national system that monitored adverse reactions associated with fluoxetine over a 4-year period, and determined whether these adverse reactions were causally related to fluoxetine.
RESULTS: In reports of adverse reactions in 5,555 patients given fluoxetine throughout New Zealand, there were 15 notifications of extrapyramidal events probably or possibly caused by fluoxetine. Fluoxetine was the only psychotropic agent used for seven of the 15 patients; two patients were also taking lithium, four were taking neuroleptics, two were taking tricyclic antidepressants, and one was taking metoclopramide.
CONCLUSIONS: The authors conclude that fluoxetine may be associated with extrapyramidal reactions. These may occur with fluoxetine alone or fluoxetine may facilitate the reaction in patients receiving psychotropic medication or dopamine receptor blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7802102     DOI: 10.1176/ajp.152.1.122

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  11 in total

1.  Do SSRI Antidepressants Increase The Risk of Extrapyramidal Side Effects In Patients Taking Antipsychotics?

Authors:  Matthew Allsbrook; Brant E Fries; Kristina L Szafara; Randolph E Regal
Journal:  P T       Date:  2016-02

Review 2.  Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management.

Authors:  Flora Coker; David Taylor
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 3.  Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.

Authors:  Toshihito Suzuki; Hisashi Matsuzaka
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 5.  Clinically significant interactions of psychotropic agents with antipsychotic drugs.

Authors:  M C Meyer; R J Baldessarini; D C Goff; F Centorrino
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

6.  Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report.

Authors:  Christos Christodoulou; Athanasia Papadopoulou; Emmanouil Rizos; Kalliopi Tournikioti; Xenia Gonda; Athanassios Douzenis; Lefteris Lykouras
Journal:  Ann Gen Psychiatry       Date:  2010-01-18       Impact factor: 3.455

7.  Neurological and cardiovascular adverse events associated with antimanic treatment in children and adolescents.

Authors:  Jeanette M Jerrell
Journal:  CNS Neurosci Ther       Date:  2009-09-21       Impact factor: 5.243

8.  Non-neurological surgery results in a neurochemical stress response.

Authors:  R Anckarsäter; H Zetterberg; J-E Månsson; K Blennow; H Anckarsäter
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

Review 9.  Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review.

Authors:  Anelyssa D'Abreu; Joseph H Friedman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-08-31

10.  Akathisia as an Extrapyramidal Side Effect of Fluoxetine.

Authors:  Ijeoma Ajufo; Tajudeen O Basiru
Journal:  Cureus       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.